Log in
Enquire now
Arsanis

Arsanis

A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases

OverviewStructured DataIssuesContributors

Contents

arsanis.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Location
Vienna
Vienna
United States
United States
B2X
B2B
B2B
0
Founder
Errik Anderson
Errik Anderson
AngelList URL
angel.co/arsanis
Number of Employees (Ranges)
11 – 50
Full Address
Winter Street, Waltham, MA 02451, US
Investors
SV Health Investors
SV Health Investors
NeoMed
NeoMed
EMBL Ventures
EMBL Ventures
‌
Anna Maria and Stephen Kellen Foundation
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Polaris Partners
Polaris Partners
OrbiMed
OrbiMed
...
Founded Date
2010
Total Funding Amount (USD)
75,500,000
Latest Funding Round Date
April 2017
Latest Funding Type
Series D
Series D
Patents Assigned (Count)
3
Wellfound ID
arsanis

Other attributes

Company Operating Status
Active
Public/Private
Public
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Arsanis

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.